Pfizer estimates that it will rake in record-breaking earnings of more than $100 billion this year due to sales of its COVID-19 vaccine and antiviral pill to treat the virus. Read More
Pfizer forecasts $54 billion in revenue in 2022 from sales of its COVID-19 vaccine and antiviral pill alone fueling an expected record of $102 billion
Reading Time: < 1 minute